Join to View Full Profile
2001 4th AveSan Diego, CA 92101
Phone+1 619-446-1727
Fax+1 858-616-8090
Dr. Sakoulas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Infectious Disease, 1999 - 2002- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1995 - 1999
Harvard Medical SchoolClass of 1995
Certifications & Licensure
CA State Medical License 2007 - 2027
MA State Medical License 1997 - 2012
NY State Medical License 2002 - 2011
American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- Risk Factors for Hospital Readmission Following Outpatient Parenteral Antimicrobial Therapy (OPAT).Melanie Yousif, Matthew Geriak, Logan Vasina, George Sakoulas
Infectious Diseases and Therapy. 2025-08-01 - 4 citationsEnhanced Killing of Methicillin-Resistant Staphylococcus aureus With Ceftaroline or Vancomycin in Combination With Carbapenems.Allen Jankeel, Gabriel Pérez-Parra, Anuj K Khetarpal, Ivan A Alvarado, Victor Nizet
The Journal of Infectious Diseases. 2025-07-30 - Colistin exerts potent activity against mcr+ Enterobacteriaceae via synergistic interactions with the host defense.Monika Kumaraswamy, Angelica Montenegro Riestra, Anabel Flores, Samira Dahesh, Fatemeh Askarian
The Journal of Clinical Investigation. 2025-06-16
Authored Content
- Listeria Monocytogenes Endocarditis: Case Report, Review of the Literature, and Laboratory Evaluation of Potential Novel Antibiotic SynergiesJanuary 2018
- Listeria Monocytogenes Endocarditis: Case Report, Review of the Literature, and Laboratory Evaluation of Potential Novel Antibiotic SynergiesJanuary 2018
- Another Look at Antimicrobial Prophylaxis for Dental Procedures in Patients with Prosthetic Heart ValvesOctober 2017
Press Mentions
04 Dec COVID-19: IVIG Reduced Progression to Ventilator and Shortened Hospital Stays in Sicker PatientsDecember 4th, 2020- Octapharma USA Presents Results of Investigational Use of Octagam® 10% for Severe COVID-19 Patients at ASH Annual MeetingDecember 2nd, 2020
- Intravenous Immunoglobulin Significantly Reduces Respiratory Morbidity in COVID-19 Study Supported by OctapharmaSeptember 9th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
